Cite
HARVARD Citation
Stratmann, J. et al. (2022). Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis. Therapeutic advances in medical oncology. p. . [Online].